Sign in

CIK 0002131524 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Braveheart Bio, Inc.

Sign in to watch
Ticker
BRVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
992981994
Phone
(415) 707-6312
Business address
ONE LETTERMAN DR., BLDG. A, STE. A4-300, SAN FRANCISCO, CA, 94129
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 8-K Event Regulation FD disclosure
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13D/A Stake Beneficial Ownership Report
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. SCHEDULE 13D Stake Beneficial Ownership Report
  10. 3 Insider Initial Statement of Ownership
  11. SCHEDULE 13D Stake Beneficial Ownership Report
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 4 Open-market buy 10% owner bought 1,100,000 shares at $18.00 ($19,800,000)
  14. 4 Open-market buy Director bought 1,940,000 shares at $18.00 ($34,920,000)
  15. 4 Open-market buy Director bought 1,940,000 shares at $18.00 ($34,920,000)
  16. 4 Conversion 10% owner acquired 7,420,091 shares (conversion)
  17. 4 Open-market buy 10% owner bought 3,600,000 shares at $18.00 ($64,800,000)
  18. 4 Open-market buy Chief Financial Officer bought 27,777 shares at $18.00 ($499,986)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 3 · 51 filings